Cargando…
Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA
Messenger RNA (mRNA) is increasingly gaining interest as a modality in vaccination and protein replacement therapy. In regenerative medicine, the mRNA-mediated expression of growth factors has shown promising results. In contrast to protein delivery, successful mRNA delivery requires a vector to ind...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565693/ https://www.ncbi.nlm.nih.gov/pubmed/36234551 http://dx.doi.org/10.3390/nano12193423 |
_version_ | 1784808953385844736 |
---|---|
author | Andrée, Lea Oude Egberink, Rik Dodemont, Josephine Hassani Besheli, Negar Yang, Fang Brock, Roland Leeuwenburgh, Sander C. G. |
author_facet | Andrée, Lea Oude Egberink, Rik Dodemont, Josephine Hassani Besheli, Negar Yang, Fang Brock, Roland Leeuwenburgh, Sander C. G. |
author_sort | Andrée, Lea |
collection | PubMed |
description | Messenger RNA (mRNA) is increasingly gaining interest as a modality in vaccination and protein replacement therapy. In regenerative medicine, the mRNA-mediated expression of growth factors has shown promising results. In contrast to protein delivery, successful mRNA delivery requires a vector to induce cellular uptake and subsequent endosomal escape to reach its end destination, the ribosome. Current non-viral vectors such as lipid- or polymer-based nanoparticles have been successfully used to express mRNA-encoded proteins. However, to advance the use of mRNA in regenerative medicine, it is required to assess the compatibility of mRNA with biomaterials that are typically applied in this field. Herein, we investigated the complexation, cellular uptake and maintenance of the integrity of mRNA complexed with gelatin nanoparticles (GNPs). To this end, GNPs with positive, neutral or negative surface charge were synthesized to assess their ability to bind and transport mRNA into cells. Positively charged GNPs exhibited the highest binding affinity and transported substantial amounts of mRNA into pre-osteoblastic cells, as assessed by confocal microscopy using fluorescently labeled mRNA. Furthermore, the GNP-bound mRNA remained stable. However, no expression of mRNA-encoded protein was detected, which is likely related to insufficient endosomal escape and/or mRNA release from the GNPs. Our results indicate that gelatin-based nanomaterials interact with mRNA in a charge-dependent manner and also mediate cellular uptake. These results create the basis for the incorporation of further functionality to yield endosomal release. |
format | Online Article Text |
id | pubmed-9565693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95656932022-10-15 Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA Andrée, Lea Oude Egberink, Rik Dodemont, Josephine Hassani Besheli, Negar Yang, Fang Brock, Roland Leeuwenburgh, Sander C. G. Nanomaterials (Basel) Article Messenger RNA (mRNA) is increasingly gaining interest as a modality in vaccination and protein replacement therapy. In regenerative medicine, the mRNA-mediated expression of growth factors has shown promising results. In contrast to protein delivery, successful mRNA delivery requires a vector to induce cellular uptake and subsequent endosomal escape to reach its end destination, the ribosome. Current non-viral vectors such as lipid- or polymer-based nanoparticles have been successfully used to express mRNA-encoded proteins. However, to advance the use of mRNA in regenerative medicine, it is required to assess the compatibility of mRNA with biomaterials that are typically applied in this field. Herein, we investigated the complexation, cellular uptake and maintenance of the integrity of mRNA complexed with gelatin nanoparticles (GNPs). To this end, GNPs with positive, neutral or negative surface charge were synthesized to assess their ability to bind and transport mRNA into cells. Positively charged GNPs exhibited the highest binding affinity and transported substantial amounts of mRNA into pre-osteoblastic cells, as assessed by confocal microscopy using fluorescently labeled mRNA. Furthermore, the GNP-bound mRNA remained stable. However, no expression of mRNA-encoded protein was detected, which is likely related to insufficient endosomal escape and/or mRNA release from the GNPs. Our results indicate that gelatin-based nanomaterials interact with mRNA in a charge-dependent manner and also mediate cellular uptake. These results create the basis for the incorporation of further functionality to yield endosomal release. MDPI 2022-09-29 /pmc/articles/PMC9565693/ /pubmed/36234551 http://dx.doi.org/10.3390/nano12193423 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Andrée, Lea Oude Egberink, Rik Dodemont, Josephine Hassani Besheli, Negar Yang, Fang Brock, Roland Leeuwenburgh, Sander C. G. Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA |
title | Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA |
title_full | Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA |
title_fullStr | Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA |
title_full_unstemmed | Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA |
title_short | Gelatin Nanoparticles for Complexation and Enhanced Cellular Delivery of mRNA |
title_sort | gelatin nanoparticles for complexation and enhanced cellular delivery of mrna |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9565693/ https://www.ncbi.nlm.nih.gov/pubmed/36234551 http://dx.doi.org/10.3390/nano12193423 |
work_keys_str_mv | AT andreelea gelatinnanoparticlesforcomplexationandenhancedcellulardeliveryofmrna AT oudeegberinkrik gelatinnanoparticlesforcomplexationandenhancedcellulardeliveryofmrna AT dodemontjosephine gelatinnanoparticlesforcomplexationandenhancedcellulardeliveryofmrna AT hassanibeshelinegar gelatinnanoparticlesforcomplexationandenhancedcellulardeliveryofmrna AT yangfang gelatinnanoparticlesforcomplexationandenhancedcellulardeliveryofmrna AT brockroland gelatinnanoparticlesforcomplexationandenhancedcellulardeliveryofmrna AT leeuwenburghsandercg gelatinnanoparticlesforcomplexationandenhancedcellulardeliveryofmrna |